Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.71 USD | -1.81% | -1.81% | -6.23% |
Feb. 12 | Acasti Pharma Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 | CI |
Feb. 07 | Craig-Hallum Initiates Acasti Pharma With Buy Rating, $6 Price Target | MT |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Neutral | Bullish | Neutral |
Resistance | 3.450 | 3.450 | 3.450 |
Spread/Res. | -21.45% | -21.45% | -21.45% |
Spread/Supp. | +1.12% | +1.12% | +53.11% |
Support | 2.680 | 2.680 | 1.770 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- ACST Stock
- Charts Acasti Pharma Inc.